VINC Vincerx Pharma, Inc.
0.0150USD0.00%Mkt Cap: 68045 $P/E: —21d ago
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States. Its VersAptx b…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap68.05K USD
Enterprise Value-4.36M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-30.07M USD
Revenue/Share—
Last Price0.0150 USD
Fiscal Year EndDec 2024
MR QuarterMar 2025
Employees12
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.02
PEG—
EV/EBITDA0.17
EV/Revenue—
P/S—
P/B0.03
EPS (TTM)-9.05
EPS (Forward)-0.67
52W Range
0.001020% of range0.0700
52W High0.0700 USD
52W Low0.0010 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-1104.04%
ROA-375.69%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-26.13M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-23317.47%
Net Debt-4.44M USD
Net Debt/EBITDA0.18
Balance Sheet
Debt/Equity0.00
Current Ratio1.79
Quick Ratio1.69
Book Value/Sh0.40 USD
Cash/Share0.85 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJan 28, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.23M
Float4.75M
Insiders4.07%
Institutions5.26%
Short Interest
Short Ratio0.1d
Short % Float2.64%
Short % Out.2.55%
Shares Short133.31K
Short (prev mo.)68.81K
Technical
SMA 500.0138 (+9.0%)
SMA 2000.0133 (+13.2%)
Beta1.46
S&P 52W Chg16.45%
Avg Vol (30d)3.50K
Avg Vol (10d)320
Technical Indicators
RSI (14)88.5
MACD0.0005
MACD Signal0.0003
MACD Hist.+0.0002
BB Upper0.0155 USD
BB Middle0.0136 USD
BB Lower0.0117 USD
BB Width27.66%
ATR (14)0.0001 USD
Vol Ratio (20d)0.00x